USE OF IMINO SUGARS IN IMMUNOTHERAPY

摘要

Described are uses for various imino sugars in PRR-mediated immunotherapy or immunoprophylaxis. In particular, the invention relates to the use of imino sugar PRR (particularly C-type lectin) ligands in immune response variegation and/or the stimulation of immune surveillance (for example by the innate immune system) and/or non-specific immunoprophylaxis. The invention therefore finds application in the treatment of pathological variegated states (for example those arising from pathogen-mediated immune system subversion or immune system dysfunction) and for inhibiting or postponing neutrophil apoptosis.